A Wild Ride – Biotech Trends 2014 -Young & Partners Pharmaceutical Executive Article (March 10, 2015)
Article looks at the positive Biotech M&A, Stock Market and IPO developments and drivers
Chemicals’ M&A activity increased in 2014 – Chemical Week interviews Peter Young (March 9-13, 2015 issue)
Chemical Week talks to Peter Young of Young & Partners about what happened in M&A in 2014 and why
Global Chemical M&A Activity to remain strong in ’15 (ICIS March 3, 2015 issue)
Editor-in-Chief explores Young & Partners' view of where M&A is headed in 2015
Activists Attack Chemicals (Young & Partners article in ICIS Chemical Business Jan 26 – Feb 2, 2015 issue)
Young & Partners explains why shareholder activists are targeting chemicals and what management should do
Equity and Debt Markets Split (Young & Partners Article in ICIS Chemical Business Dec. 22 – Jan. 4, 2015 issue)
The love hate relationship that the Chemicals has with the debt, equity and IPO markets
Chemical Week Magazine – Young & Partners Interview (December 8, 2014 issue)
Peter Young of Young & Partners explains the underlying dynamics of current M&A market trends
M&A Stepping on the Accelerator (Young & Partners Article in ICIS Chemical Business Dec. 8-14, 2014 issue)
An examination of the current surge in Chemical M&A activity and where it is headed
Pharma and Biotech Financial Trends – A Frenzy of Activity (Young & Partners article written for the Pharma Exec Dec 2014 Issue)
Young & Partners dissects the drivers behind the frenzy of biopharma M&A and financial activity
The Normal and Abnormal in Equity (Young & Partners Article in ICIS Chemical Business October 6-12, 2014 issue)
The disconnect between high valuations of public stocks and low demand for chemical IPOs
Chemical M&A solid in first half, expected to rise (Young & Partners interview in Chemical Week -September 22 – 29, 2014 issue)
Peter Young dissects the strong M&A activity and what is happening in the financing markets